Dr. Philippe Autier, vice-President Population Research of the International Prevention Research Institute (iPRI),  participated in a radio debate on Mammagraphy Screening on French radio station “France Inter”. “Breast cancer: how about screening? Mammography screening is at the centre of a scientific contreversy for several years.” To hear the whole debate (in French), click here.  

Read More

iPRI calls for an independent inquiry into the effectiveness of Mammographic Screening for Breast Cancer and supports the review ordered by the Secretary of State for Health and Social Care Health into the recent error made by England’s National Health Service that reportedly excluded 450,000 women from a previously promised mammography. Breast cancer is the…

Read More

An in-depth review of randomised trials on screening for breast, colo-rectal, cervical, prostate and lung cancers, published today in the Journal of the Royal Society of Medicine, shows that the benefits of mammographic screening are likely to have been over-estimated.

Read More

NEWS RELEASE Amsterdam, The Netherlands / Lyon, France, 29 September 2013 — Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience more harm than good from routine PSA screening, according to research to…

Read More

An international team of researchers from France, the UK and Norway coordinated by Philippe Autier, Research Director at the International Prevention Research Institute (iPRI) found that better treatment and improving health systems are more likely to have led to falling numbers of deaths from breast cancer than screening which was published in the British Medical…

Read More